flibanserin Articles
Boehringer Ingelheim drops female SF drug flibanserin after negative regulatory feedback
11 October 2010
Boehringer Ingelheim’s “female Viagra” flibanserin fails to meet efficacy endpoints, say US FDA reviewers
17 June 2010
Showing 1-3 of 3 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
